Sharp Rise in NDM-CRE Infections
A recent CDC report reveals a significant surge in infections caused by New Delhi metallo-β-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE) in the United States. Between 2019 and 2023, cases increased by over 460%. These infections, which include bloodstream infections, pneumonia, urinary tract infections, and wound infections, are difficult to treat and can be life-threatening.
Challenges in Detection and Treatment
NDM-CRE infections are hard to identify due to limited laboratory testing capabilities, making early detection a major challenge. The bacteria are resistant to many of the strongest antibiotics, complicating treatment and increasing the risk of severe outcomes. Health officials emphasize the need for rapid detection and appropriate infection control measures to prevent further spread.
Implications for Public Health
The rise in NDM-CRE adds to the ongoing concern over antibiotic-resistant infections in the U.S., which caused thousands of infections and deaths annually. Public health experts stress the importance of increased awareness, improved diagnostic testing, and the development of new treatment strategies to address this growing threat.
